Solution Consultant
Pubblicato il 19-10-2026 - Medidata Solutions in Segrate
Solution Consultant – Senior Industry Process Consultant
At Medidata (a Dassault Systèmes company), we are leading the digital transformation of life sciences, creating hope for millions of patients. We help generate the evidence and insights that enable pharmaceutical, biotech, medical device, diagnostics companies, and academic researchers, to accelerate value, minimize risk, and optimize clinical outcomes.
By joining us, you become part of the world's most trusted platform for clinical development, commercialization, and real-world data. Together, Dassault Systèmes and Medidata provide an unparalleled, integrated business and scientific platform that spans discovery, preclinical development, clinical trials, and commercialization.
Your Mission
The Senior Industry Process Consultant (Sr. IPC) serves as a solution consulting authority within the Life Sciences sales organization.This role is a strategic bridge between complex platform capabilities and tangible business outcomes, acting as a "trusted advisor" to both the Sales organization and the customer.
By aligning high‑level clinical, financial, and operational challenges with the broader Medidata and Dassault ecosystem, the CSC moves beyond tactical support to orchestrate pre‑sales engagements with complete autonomy. Partnering directly with Client Executives (CEs) and Customer Success Managers (CSMs), you will form a powerful account triad to drive complex clinical trial technology sales cycles within mid‑market biopharma accounts.
This is not a click‑through demo role. Your mission is to move beyond tactical feature delivery to understand our customers' deepest operational challenges, mapping our industry‑leading solutions into high‑value business narratives that prioritize "why" over "how" to secure technical wins and ensure sustainable long‑term value realization.
Key Responsibilities
- Serve as a Trusted Advisor to executive, clinical, technical, and operational leadership across mid‑market account